# Safety and Efficacy of TRPP Therapy in Glioblastoma Multiforme

> **NCT05589961** · EARLY_PHASE1 · UNKNOWN · sponsor: **The Second Hospital of Hebei Medical University** · enrollment: 10 (estimated)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

- **DRUG:** TMZ

## Key facts

- **NCT ID:** NCT05589961
- **Lead sponsor:** The Second Hospital of Hebei Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10
- **Primary completion:** 2024-07
- **Final completion:** 2024-07
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2022-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05589961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05589961, "Safety and Efficacy of TRPP Therapy in Glioblastoma Multiforme". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05589961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*